Ionis Pharmaceuticals Inc (IONS) Stock: What the Analysts are Saying
The stock has a 36-month beta value of 0.17. Opinions on the stock are mixed, with 12 analysts rating it as a “buy,” 5 as
The stock has a 36-month beta value of 0.17. Opinions on the stock are mixed, with 12 analysts rating it as a “buy,” 5 as
Additionally, the 36-month beta value for IONS is 0.17. There are mixed opinions on the stock, with 12 analysts rating it as a “buy,” 5
The stock of Ionis Pharmaceuticals Inc (IONS) has gone up by 2.69% for the week, with a -4.30% drop in the past month and a
The stock price of Ionis Pharmaceuticals Inc (NASDAQ: IONS) has surged by 1.62 when compared to previous closing price of 29.10, but the company has
The stock of Ionis Pharmaceuticals Inc (IONS) has gone down by -3.27% for the week, with a -15.92% drop in the past month and a
Ionis Pharmaceuticals Inc (NASDAQ: IONS)’s stock price has decreased by -9.65 compared to its previous closing price of 30.17. However, the company has seen a
Ionis Pharmaceuticals Inc (NASDAQ: IONS) has experienced a decline in its stock price by -3.53 compared to its previous closing price of 33.45. However, the
The 36-month beta value for IONS is at 0.24. Analysts have varying views on the stock, with 13 analysts rating it as a “buy,” 4
© 2024, Powered by Smart TechOne